Efficacy and Safety of Biosimilar Ranibizumab (OPTIMAB®) versus Innovator Ranibizumab in Patients with Neovascular (Wet) Age-Related Macular Degeneration: A Double-Blind, Randomized, Multicenter, Phase III Study.

Autor: Rana, Parth J (AUTHOR), Deshmukh, Himanshu (AUTHOR), Shah, Urmil (AUTHOR), Kumar, Vinod (AUTHOR), Kanungo, Sanghamitra (AUTHOR), Singhal, Deepika (AUTHOR), Mahapatra, Santosh Kumar (AUTHOR), Vakharia, Ira (AUTHOR), Jaiswal, Mukesh (AUTHOR), Gondane, Ajitkumar (AUTHOR), Vaidya, Pooja (AUTHOR), Shahavi, Vinayaka (AUTHOR), Shandilya, Harish (AUTHOR), Pawar, Dattatray (AUTHOR), Sharma, Akhilesh (AUTHOR)
Zdroj: Clinical Ophthalmology. Oct2024, Vol. 18, p3071-3081. 11p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje